New LigaSure™ Maryland Thoracic Device

We're working hard to transform lung health - from identifying patients earlier to optimizing treatment to accelerating recovery. It's why we're committed to offering a comprehensive suite of technologies tailored for thoracic surgery.


Now, thoracic surgeons can use an advanced energy device made specifically for their procedures.1,2,3,4,5

It can help you:

  • Seal and divide pulmonary veins and arteries up to and including 7mm6
  • Seal and transect adhesions6
  • Dissect lymph nodes6

Reliable LigaSure™ technology comes to Lung Health. That's good news for surgeons - and your patients.

LigaSure™ Maryland Thoracic Value Analysis Brief


The LigaSure™ Maryland thoracic device provides:

  • A one-step vessel sealer6
  • A Maryland dissector for enhanced blunt dissection7,8,†
  • An attraumatic grasper to securely grasp tissue7,8,‡
  • Cold scissors to leave the critical decision to cut in the surgeon's hands6,7

  • †23 of 32 surveyed after use agreed when compared to surgeon’s primary device.

  • ‡33 of 33 surgeons surveyed after use agreed when compared to surgeon’s primary device.

  • 1. Based on internal report #RE00138840, LIG-45 memo, device length recommendation, thoracic(LF1930T). Feb. 6, 2018.

  • 2. Based on internal test report #RE00125866, Jaw force and gap range burst pressure evaluation of EB4thoracic Maryland device (LF1930T); conducted on bovine tissue. Nov. 20–21, 2017 and Nov. 27–30, 2017.

  • 3. Based on internal test report #RE00134865, Burst pressure verification of pulmonary bovine veins usingthe LigaSure™ LF1930T device. Jan. 17–18, 2018.

  • 4. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLPchronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.

  • 5. Based on internal test report #RE00128442, GLP acute pulmonary vasculature hemostasis verificationstudy of the LigaSure™ LF1930T device in hounds. Dec. 8, 2017.

  • 6. LigaSure™ Maryland Jaw Thoracic Sealer/Divider, Nano-Coated [instructions for use]. Boulder, CO:Medtronic; 2017.

  • 7. Based on internal test report #RE00140529 rev A, LigaSure™ Maryland device, nano-coated (LF19XX)tissue testing (memo). March 5, 2018.

  • 8. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independentsurgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.

Provide details to continue

  • Your information will be protected in accordance with our privacy statement.

The site needs to use cookies to store information in your web browser, to make this site work. By clicking “Submit” you consent to the placement of these cookies. Learn more about our cookie policy.